Chemoinformaics analysis of Methyl Tritriacontanoate
| Molecular Weight | 508.916 | nRot | 31 |
| Heavy Atom Molecular Weight | 440.372 | nRig | 5 |
| Exact Molecular Weight | 508.522 | nRing | 0 |
| Solubility: LogS | -3.875 | nHRing | 0 |
| Solubility: LogP | 3.865 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 104 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 68 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 103.726 |
| nHD | 0 | BPOL | 70.8221 |
| QED | 0.489 |
| Synth | 2.94 |
| Natural Product Likeliness | 1.194 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.324 |
| MDCK | 0.0000148 |
| BBB | 0.928 |
| PPB | 0.918042 |
| VDSS | 2.387 |
| FU | 0.0798771 |
| CYP1A2-inh | 0.861 |
| CYP1A2-sub | 0.893 |
| CYP2c19-inh | 0.218 |
| CYP2c19-sub | 0.88 |
| CYP2c9-inh | 0.425 |
| CYP2c9-sub | 0.684 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.571 |
| CYP3a4-inh | 0.185 |
| CYP3a4-sub | 0.309 |
| CL | 9.785 |
| T12 | 0.301 |
| hERG | 0.031 |
| Ames | 0.016 |
| ROA | 0.054 |
| SkinSen | 0.574 |
| Carcinogencity | 0.144 |
| EI | 0.988 |
| Respiratory | 0.68 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.512746 |